Antidiscrimination Laws and Kidney Transplant for Patients With Developmental Disabilities - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Disability Antidiscrimination Laws and Kidney Transplant Access for Patients With Developmental Disabilities

  • By

  • Brittany N. Hand

  • J. Madison Hyer

  • Melica Nikahd

  • Andrew Gothard

  • Guy Brock

  • John Gardner

  • Lauren Bishop

  • Lindsay Shea

  • Lauren Wang

  • Austin D. Schenk

  • November 1, 2026

Share

  • 1

    In matched Medicare cohorts, patients with IDD had lower rates of kidney transplant evaluation (IRR, 0.78; 95% CI, 0.75-0.81) and receipt (IRR, 0.62; 95% CI, 0.57-0.66) than controls.

  • 2

    Among 12,730 patients with IDD and 49,199 matched controls, passage of a state disability antidiscrimination law was not significantly associated with disparities in transplant evaluation or receipt.

  • 3

    Within the IDD group, transplant evaluation and receipt rates did not differ significantly according to whether laws included expedited review or a private right of action.

  • 4

    Sensitivity analyses produced findings similar to the primary analyses, including analyses of patients who did not cross state lines and states that changed laws during the study period.

  • 5

    The study lacked measures of transplant appropriateness and social support and could not determine whether some patients chose not to pursue evaluation or transplantation.

Original Source(s)

Antidiscrimination Laws and Kidney Transplant for Patients With Developmental Disabilities

  • by Brittany N. Hand, J. Madison Hyer, Melica Nikahd, Andrew Gothard, Guy Brock, John Gardner, Lauren Bishop, Lindsay Shea, Lauren Wang, Austin D. Schenk

  • November 1, 2026

Related Content

May long COVID improve without full recovery?

Investigators found that symptom improvement remained possible years after infection, but patients with multisystem symptoms had lower likelihood of improvement.

Defining ARDS: globalization and personalization to better serve the world—part 2

Prognostic Biomarkers for Chagas Disease

New research identifies metabolic signatures that could help predict which patients with Chagas disease are most likely to develop serious cardiac complications

  • November 3, 2026

  • 2 min